ctrl K

Watchlist Price Alert

Eliem Therapeutics Inc. (ELYM)

NASDAQ: ELYM · Real-Time Price · USD

5.11

-0.05 (-0.97%)

At close: Oct 02, 2024, 8:00 PM

Eliem Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a
Operating Income	-21.47M	-45.13M	-35.67M	-20.93M	-7.45M
Interest Income	n/a	1.2K	450.00	n/a	n/a
Pretax Income	-35.12M	-45.24M	-47.48M	-20.67M	-6.55M
Net Income	-35.12M	-45.35M	-47.48M	-11.51M	-3.8M
Selling & General & Admin	9.89M	18.92M	12.35M	2.42M	677K
Research & Development	15.41M	26.21M	23.32M	9.34M	4.02M
Other Expenses	n/a	1.38M	-11.64M	n/a	914K
Operating Expenses	37.41M	45.13M	35.67M	11.77M	4.7M
Interest Expense	n/a	1.59M	n/a	n/a	n/a
Selling & Marketing Expenses	24.85M	n/a	n/a	n/a	n/a
Cost & Expenses	37.41M	45.13M	35.67M	11.77M	4.7M
Income Tax Expense	-21.47K	109K	-66.56K	-9.16M	-2.75M
Shares Outstanding (Basic)	26.99M	26.31M	26.24M	26.32M	26.32M
Shares Outstanding (Diluted)	26.99M	26.31M	26.24M	26.32M	26.32M
EPS (Basic)	-1.3	-1.72	-1.81	-0.44	-0.14
EPS (Diluted)	-1.3	-1.72	-1.81	-0.44	-0.14
EBITDA	-13.65M	-43.65M	-35.5M	-2.87M	-1.93M
EBIT	n/a	-43.65M	n/a	n/a	n/a
Depreciation & Amortization	21.47M	45.13M	35.67M	11.77M	4.7M